Home » Topics » Regulatory

Regulatory
RSS

FDA approves new indication for Byetta

Oct. 20, 2011

FDA approves Merck & Co.'s Juvisync

Oct. 10, 2011

FDA approves Lilly's Cialis for new indications

Oct. 7, 2011

Pfizer launches BeneFIX RTS in Europe

Oct. 4, 2011

Mucosta approved in Japan for dry eye syndrome

Sep. 27, 2011

FDA approves new indication for Soliris

Sep. 27, 2011

Japanese authorities extend indication of Venogloblulin

Sep. 27, 2011

Asahi Kasei Pharma clear to market osteoporosis therapy in Japan

Sep. 27, 2011

Remicade approved in U.S. for new indication

Sep. 26, 2011

Avastin approved for new indication in Japan

Sep. 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...